The ECU Health Medical Center is expanding heart care with two new technologies for transcatheter tricuspid valve replacement. The new technologies are EVOQUE™, a ...

Where this device will fit in with other emerging options remains to be seen, but it might hold an advantage in large annuli.

Two state-of-the-art new technologies for transcatheter tricuspid valve replacements is expanding advanced heart care with ...

Inc. (Stock Code: 2500.HK, hereinafter referred to as 'Venus Medtech' or the 'Company'), a global leader in structural heart therapies, has announced financial results for the year ended December 31, ...

Adhering to the principles of evidence-based medicine, Venus Medtech has consistently conducted long-term follow-up studies ...